[Clinical observations with the new saluretic 2,3-dichlor-4-(2-methylene-butryl-phenoxy-acetic acid (ethacrynic acid)].
D000328:Adult; D001795:Blood Pressure Determination; D002713:Chlorine / Q000097:blood; D004232:Diuretics; D004487:Edema / Q000188:drug therapy*; D004976:Ethacrynic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists; D009584:Nitrogen / Q000097:blood; D011188:Potassium / Q000097:blood; D012964:Sodium / Q000097:blood; D014527:Uric Acid / Q000097:blood
D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists; D014527:Uric Acid; D002713:Chlorine; D012964:Sodium; D004976:Ethacrynic Acid; D009584:Nitrogen; D011188:Potassium
Klinische Beobachtungen mit dem neuen Salureticum 2,3-Dichlor-4-(2-methylenbutyryl)-phenoxy-essigsäure (Etacrynsäure)